![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KREMEN1 |
Gene summary for KREMEN1 |
![]() |
Gene information | Species | Human | Gene symbol | KREMEN1 | Gene ID | 83999 |
Gene name | kringle containing transmembrane protein 1 | |
Gene Alias | ECTD13 | |
Cytomap | 22q12.1 | |
Gene Type | protein-coding | GO ID | GO:0001503 | UniProtAcc | Q96MU8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
83999 | KREMEN1 | P30T-E | Human | Esophagus | ESCC | 6.78e-33 | 1.34e+00 | 0.137 |
83999 | KREMEN1 | P31T-E | Human | Esophagus | ESCC | 1.70e-18 | 2.71e-01 | 0.1251 |
83999 | KREMEN1 | P32T-E | Human | Esophagus | ESCC | 3.02e-11 | 2.45e-01 | 0.1666 |
83999 | KREMEN1 | P36T-E | Human | Esophagus | ESCC | 5.56e-05 | 1.88e-01 | 0.1187 |
83999 | KREMEN1 | P37T-E | Human | Esophagus | ESCC | 1.74e-23 | 5.08e-01 | 0.1371 |
83999 | KREMEN1 | P39T-E | Human | Esophagus | ESCC | 1.71e-10 | 2.92e-01 | 0.0894 |
83999 | KREMEN1 | P40T-E | Human | Esophagus | ESCC | 1.46e-06 | 4.60e-01 | 0.109 |
83999 | KREMEN1 | P42T-E | Human | Esophagus | ESCC | 1.28e-26 | 5.93e-01 | 0.1175 |
83999 | KREMEN1 | P44T-E | Human | Esophagus | ESCC | 4.65e-08 | 2.49e-01 | 0.1096 |
83999 | KREMEN1 | P47T-E | Human | Esophagus | ESCC | 7.09e-10 | 2.71e-01 | 0.1067 |
83999 | KREMEN1 | P48T-E | Human | Esophagus | ESCC | 1.54e-25 | 4.85e-01 | 0.0959 |
83999 | KREMEN1 | P49T-E | Human | Esophagus | ESCC | 1.18e-10 | 8.54e-01 | 0.1768 |
83999 | KREMEN1 | P52T-E | Human | Esophagus | ESCC | 5.87e-24 | 5.06e-01 | 0.1555 |
83999 | KREMEN1 | P54T-E | Human | Esophagus | ESCC | 4.17e-12 | 3.30e-01 | 0.0975 |
83999 | KREMEN1 | P56T-E | Human | Esophagus | ESCC | 5.13e-13 | 1.33e+00 | 0.1613 |
83999 | KREMEN1 | P57T-E | Human | Esophagus | ESCC | 8.04e-14 | 2.08e-01 | 0.0926 |
83999 | KREMEN1 | P61T-E | Human | Esophagus | ESCC | 1.11e-10 | 2.45e-01 | 0.099 |
83999 | KREMEN1 | P62T-E | Human | Esophagus | ESCC | 7.82e-26 | 5.38e-01 | 0.1302 |
83999 | KREMEN1 | P65T-E | Human | Esophagus | ESCC | 2.18e-16 | 3.16e-01 | 0.0978 |
83999 | KREMEN1 | P74T-E | Human | Esophagus | ESCC | 9.10e-24 | 6.48e-01 | 0.1479 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00160557 | Cervix | CC | Wnt signaling pathway | 98/2311 | 444/18723 | 4.82e-09 | 4.65e-07 | 98 |
GO:01987387 | Cervix | CC | cell-cell signaling by wnt | 98/2311 | 446/18723 | 6.16e-09 | 5.58e-07 | 98 |
GO:00301117 | Cervix | CC | regulation of Wnt signaling pathway | 76/2311 | 328/18723 | 3.05e-08 | 2.08e-06 | 76 |
GO:19030349 | Cervix | CC | regulation of response to wounding | 44/2311 | 167/18723 | 6.33e-07 | 2.31e-05 | 44 |
GO:00608287 | Cervix | CC | regulation of canonical Wnt signaling pathway | 58/2311 | 253/18723 | 1.83e-06 | 5.89e-05 | 58 |
GO:00600707 | Cervix | CC | canonical Wnt signaling pathway | 66/2311 | 303/18723 | 2.47e-06 | 7.35e-05 | 66 |
GO:00109757 | Cervix | CC | regulation of neuron projection development | 88/2311 | 445/18723 | 4.26e-06 | 1.09e-04 | 88 |
GO:00310996 | Cervix | CC | regeneration | 46/2311 | 198/18723 | 1.43e-05 | 2.84e-04 | 46 |
GO:00615647 | Cervix | CC | axon development | 89/2311 | 467/18723 | 1.71e-05 | 3.27e-04 | 89 |
GO:00313456 | Cervix | CC | negative regulation of cell projection organization | 39/2311 | 186/18723 | 5.86e-04 | 5.57e-03 | 39 |
GO:00321022 | Cervix | CC | negative regulation of response to external stimulus | 75/2311 | 420/18723 | 5.96e-04 | 5.61e-03 | 75 |
GO:00301784 | Cervix | CC | negative regulation of Wnt signaling pathway | 35/2311 | 170/18723 | 1.52e-03 | 1.17e-02 | 35 |
GO:00015037 | Cervix | CC | ossification | 71/2311 | 408/18723 | 1.67e-03 | 1.28e-02 | 71 |
GO:00487365 | Cervix | CC | appendage development | 35/2311 | 172/18723 | 1.88e-03 | 1.39e-02 | 35 |
GO:00601735 | Cervix | CC | limb development | 35/2311 | 172/18723 | 1.88e-03 | 1.39e-02 | 35 |
GO:00900901 | Cervix | CC | negative regulation of canonical Wnt signaling pathway | 29/2311 | 137/18723 | 2.40e-03 | 1.70e-02 | 29 |
GO:00109775 | Cervix | CC | negative regulation of neuron projection development | 28/2311 | 137/18723 | 4.74e-03 | 2.83e-02 | 28 |
GO:00486782 | Cervix | CC | response to axon injury | 19/2311 | 83/18723 | 5.25e-03 | 3.08e-02 | 19 |
GO:0048679 | Cervix | CC | regulation of axon regeneration | 9/2311 | 29/18723 | 6.49e-03 | 3.61e-02 | 9 |
GO:00302781 | Cervix | CC | regulation of ossification | 24/2311 | 115/18723 | 6.51e-03 | 3.61e-02 | 24 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KREMEN1 | SNV | Missense_Mutation | rs775424604 | c.479N>G | p.Phe160Cys | p.F160C | Q96MU8 | protein_coding | deleterious(0) | probably_damaging(0.935) | TCGA-AN-A0AT-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
KREMEN1 | SNV | Missense_Mutation | c.1015G>T | p.Ala339Ser | p.A339S | Q96MU8 | protein_coding | tolerated(0.38) | benign(0.019) | TCGA-E2-A14W-01 | Breast | breast invasive carcinoma | Male | >=65 | I/II | Chemotherapy | cytoxan | SD | |
KREMEN1 | SNV | Missense_Mutation | rs749155972 | c.1148N>G | p.Met383Arg | p.M383R | Q96MU8 | protein_coding | tolerated_low_confidence(0.7) | benign(0.003) | TCGA-EW-A1J3-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD |
KREMEN1 | SNV | Missense_Mutation | novel | c.1444C>T | p.Leu482Phe | p.L482F | Q96MU8 | protein_coding | benign(0.045) | TCGA-C5-A8XH-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
KREMEN1 | SNV | Missense_Mutation | novel | c.148N>T | p.Ala50Ser | p.A50S | Q96MU8 | protein_coding | tolerated(1) | benign(0.013) | TCGA-EA-A3HU-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
KREMEN1 | SNV | Missense_Mutation | novel | c.1129N>C | p.Asn377His | p.N377H | Q96MU8 | protein_coding | tolerated_low_confidence(0.33) | benign(0) | TCGA-AA-A01D-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | capecitabine | PD |
KREMEN1 | SNV | Missense_Mutation | novel | c.1130N>C | p.Asn377Thr | p.N377T | Q96MU8 | protein_coding | tolerated_low_confidence(0.61) | benign(0) | TCGA-AA-A01D-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | capecitabine | PD |
KREMEN1 | SNV | Missense_Mutation | rs751542642 | c.856N>A | p.Gly286Arg | p.G286R | Q96MU8 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-AA-A01P-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
KREMEN1 | SNV | Missense_Mutation | rs774077658 | c.500N>G | p.Tyr167Cys | p.Y167C | Q96MU8 | protein_coding | deleterious(0.05) | probably_damaging(0.964) | TCGA-AD-6895-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
KREMEN1 | SNV | Missense_Mutation | novel | c.377N>C | p.Lys126Thr | p.K126T | Q96MU8 | protein_coding | tolerated(0.23) | possibly_damaging(0.544) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |